Related references
Note: Only part of the references are listed.Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in mice
Jordi Creus-Muncunill et al.
ACTA NEUROPATHOLOGICA (2021)
Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons
Tugce Munise Satir et al.
SCIENTIFIC REPORTS (2020)
Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington's Disease
Judith Schilling et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases
Rula Zain et al.
NEUROTHERAPEUTICS (2019)
Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®
Simoneide Souza Titze de Almeida et al.
MOLECULES (2018)
Oligonucleotide therapies for disorders of the nervous system
Olga Khorkova et al.
NATURE BIOTECHNOLOGY (2017)
Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice
Ryan G. Lim et al.
NATURE NEUROSCIENCE (2017)
CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression
Eman M. Zaghloul et al.
NUCLEIC ACIDS RESEARCH (2017)
Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages
D. Vizlin-Hodzic et al.
TRANSLATIONAL PSYCHIATRY (2017)
Ataxin-2: From RNA Control to Human Health and Disease
Lauren A. Ostrowski et al.
GENES (2017)
LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts
Aleksander Touznik et al.
SCIENTIFIC REPORTS (2017)
Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels
Laura Rue et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Cell Polarity and Neurogenesis in Embryonic Stem Cell-Derived Neural Rosettes
Erin Banda et al.
STEM CELLS AND DEVELOPMENT (2015)
Oligonucleotide-based therapy for neurodegenerative diseases
Iddo Magen et al.
BRAIN RESEARCH (2014)
The roles and regulation of multicellular rosette structures during morphogenesis
Molly J. Harding et al.
DEVELOPMENT (2014)
Role of Context in RNA Structure: Flanking Sequences Reconfigure CAG Motif Folding in Huntingtin Exon 1 Transcripts
Steven Busan et al.
BIOCHEMISTRY (2013)
POU-III Transcription Factors (Brn1, Brn2, and Oct6) Influence Neurogenesis, Molecular Identity, and Migratory Destination of Upper-Layer Cells of the Cerebral Cortex
Martin H. Dominguez et al.
CEREBRAL CORTEX (2013)
A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration
Boxun Lu et al.
FASEB JOURNAL (2013)
Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNA
Pedro M. D. Moreno et al.
NUCLEIC ACIDS RESEARCH (2013)
Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
Richard Grondin et al.
BRAIN (2012)
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
CELL STEM CELL (2012)
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
Mahru C. An et al.
CELL STEM CELL (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks
Yichen Shi et al.
NATURE PROTOCOLS (2012)
hESC derived neuro-epithelial rosettes recapitulate early mammalian neurulation events; an in vitro model
Carol Lynn Curchoe et al.
STEM CELL RESEARCH (2012)
A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity
Monica Banez-Coronel et al.
PLOS GENETICS (2012)
Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
Jodi L. McBride et al.
MOLECULAR THERAPY (2011)
Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference
Mateusz de Mezer et al.
NUCLEIC ACIDS RESEARCH (2011)
A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
Maria C. N. Marchetto et al.
CELL (2010)
High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function
Claudia Fallini et al.
MOLECULAR NEURODEGENERATION (2010)
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
C. A. Stein et al.
NUCLEIC ACIDS RESEARCH (2010)
Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
Ryan L. Boudreau et al.
MOLECULAR THERAPY (2009)
Induced pluripotent stem cells from a spinal muscular atrophy patient
Allison D. Ebert et al.
NATURE (2009)
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs
Gabsang Lee et al.
NATURE (2009)
Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain
Zaman Mirzadeh et al.
CELL STEM CELL (2008)
Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1
Perla Kaliman et al.
CELLULAR SIGNALLING (2008)
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage
Yechiel Elkabetz et al.
GENES & DEVELOPMENT (2008)
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease
Marius Wernig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reprogramming of human somatic cells to pluripotency with defined factors
In-Hyun Park et al.
NATURE (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Factors associated with HD CAG repeat instability in Huntington disease
V. C. Wheeler et al.
JOURNAL OF MEDICAL GENETICS (2007)
Efficient transfection of DNA or shRNA vectors into neurons using magnetofection
Thomas Buerli et al.
NATURE PROTOCOLS (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease
M Díaz-Hernández et al.
JOURNAL OF NEUROSCIENCE (2005)
Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis
L Kennedy et al.
HUMAN MOLECULAR GENETICS (2003)
Postsynaptic activity of metabotropic glutamate receptors in the piriform cortex
M Sugitani et al.
NEUROREPORT (2002)
Transcriptional regulation of cortical neuron migration by POU domain factors
RJ McEvilly et al.
SCIENCE (2002)
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
F Scherer et al.
GENE THERAPY (2002)
Fully modified 2′ MOE oligonucleotides redirect polyadenylation
TA Vickers et al.
NUCLEIC ACIDS RESEARCH (2001)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)
Share Paper
